These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27123091)

  • 21. Evaluation of peritoneovenous shunt in refractory cirrhotic ascites in Indian patients.
    Lal M; Sahi RP; Sinha KN; Mahendra NN
    Indian J Gastroenterol; 1992 Jul; 11(3):127-8. PubMed ID: 1506049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient selection and survival after peritoneovenous shunting for nonmalignant ascites.
    Smith RE; Nostrant TT; Eckhauser FE; Wilson JP; Knol JA; Strodel WE
    Am J Gastroenterol; 1984 Aug; 79(8):659-62. PubMed ID: 6465114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peritoneovenous shunting for intractable ascites.
    Tyden G; Samnegård H; Thulin L
    Acta Chir Scand; 1982; 148(7):597-600. PubMed ID: 7168289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Percutaneous implant of Denver peritoneovenous shunt: a new opportunity for the interventional radiologist].
    Spreafico C; Patelli G; Lanocita R; Di Tolla G; Marchianò A; Frigerio L; Garbagnati F; Ticha V; Damascelli B
    Radiol Med; 2001 Sep; 102(3):154-8. PubMed ID: 11677458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous peritoneovenous shunt for treatment of refractory ascites.
    Won JY; Choi SY; Ko HK; Kim SH; Lee KH; Lee JT; Lee DY
    J Vasc Interv Radiol; 2008 Dec; 19(12):1717-22. PubMed ID: 18948021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Denver peritoneovenous shunting for malignant or cirrhotic ascites. A prospective consecutive series.
    Söderlund C
    Scand J Gastroenterol; 1986 Dec; 21(10):1161-72. PubMed ID: 3809991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poor outcome from peritoneovenous shunts for refractory ascites.
    Scholz DG; Nagorney DM; Lindor KD
    Am J Gastroenterol; 1989 May; 84(5):540-3. PubMed ID: 2719011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful Treatment of Ascites using a Denver
    Kogiso T; Hashimoto E; Ito T; Hara T; Ikarashi Y; Kodama K; Taniai M; Torii N; Yoshinaga K; Morita S; Takahashi Y; Tanaka J; Sakai S; Yamamoto M; Tokushige K
    Intern Med; 2016; 55(20):2957-2963. PubMed ID: 27746432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of refractory cirrhotic ascites: challenges and solutions.
    Fukui H; Kawaratani H; Kaji K; Takaya H; Yoshiji H
    Hepat Med; 2018; 10():55-71. PubMed ID: 30013405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous placement and management of the Denver shunt for portal hypertensive ascites.
    Martin LG
    AJR Am J Roentgenol; 2012 Oct; 199(4):W449-53. PubMed ID: 22997394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneous central venous thrombosis and shunt occlusion following peritoneovenous shunt placement for intractable ascites.
    Hariharan D; Wilkes EA; Aithal GP; Travis SJ; Lobo DN
    Ann R Coll Surg Engl; 2017 May; 99(5):e145-e147. PubMed ID: 28462645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritoneovenous shunt in treatment of ascites in patients with cirrhosis. A preliminary report with special reference to pathophysiology.
    Henriksen JH; Malchow-Møller A; Ring-Larsen H; Jensen JL; Dietrichson O; Staehr-Johansen T; Juhl E
    Scand J Gastroenterol; 1983 May; 18(4):529-35. PubMed ID: 6669928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of cirrhotic ascites.
    Schouten J; Michielsen PP
    Acta Gastroenterol Belg; 2007; 70(2):217-22. PubMed ID: 17715638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment options for cirrhotic ascites.
    Wilkinson SP
    Eur J Gastroenterol Hepatol; 1998 Jan; 10(1):1-3. PubMed ID: 9565461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Peritoneovenous shunt in resistant ascites in patients with portal hypertension].
    Tsatsanidi KN; Eramishantsev AK; Lebezev VM; Bokhian TS; Gorev VK; Shol'ts NF
    Khirurgiia (Mosk); 1990 Sep; (9):107-12. PubMed ID: 2273818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of refractory chylous ascites with peritoneovenous shunts.
    Huang Y; Gloviczki P; Duncan AA; Fleming MD; Driscoll DJ; Kalra M; Oderich GS; Bower TC
    J Vasc Surg Venous Lymphat Disord; 2017 Jul; 5(4):538-546. PubMed ID: 28623993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful use of a mesocaval shunt to treat refractory ascites in a chronic pancreatitis induced portal vein thrombosis.
    Dutta S; Pal B; Ram D; Shyamprasad SK; Ramakrishnaiah VPN
    Ann Hepatobiliary Pancreat Surg; 2022 May; 26(2):204-209. PubMed ID: 35193995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peritoneovenous shunting for cirrhotic versus malignant ascites.
    Kostroff KM; Ross DW; Davis JM
    Surg Gynecol Obstet; 1985 Sep; 161(3):204-8. PubMed ID: 2412302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peritoneovenous shunt for intractable malignant ascites. A single case report of metastatic peritoneal mesothelioma implanted via LeVeen shunt.
    Nervino HE; Gebhardt FC
    Cancer; 1984 Nov; 54(10):2231-3. PubMed ID: 6207908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.